Lisdexamfetamine, marketed as Vyvanse, is a medicated drug approved in Canada for managing Attention-Deficit/Hyperactivity Disorder (ADHD) in children and people. The medication functions as a prodrug, https://sandoz-lisdexamfetamine-747984.blogaritma.com/41317837/lisdexamfetamine-in-the-nation-a-comprehensive-guide